Monoclonal Antibodies
Anti-PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7
Item Number : CM0005952
Price varies based on specs and customizations
- Application
- FC
- Cross Reactivity
- Human
- Protein Weight
- 33kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | Rabbit anti-Human PD-L1/CD274 mAb |
| Remarks/Alias | B7-H; B7H1; PDL1; PD-L1; hPD-L1; PDCD1L1; PDCD1LG1 |
| Species | Human |
| GeneID (human) | 29126 |
| GeneID | 29126 |
| Immunogen | Recombinant protein|Recombinant fusion protein containing a sequence corresponding to amino acids 1-290 of human PD-L1/CD274 (Q9NZQ7 |
| Source | Rabbit |
| Category | Monoclonal Antibodies |
| Application | FC |
| Cross Reactivity | Human |
| SWISS | Q9NZQ7 |
| Protein Weight | 33kDa |
| Shipping | Ice bag |
Biological Background: PD-L1/CD274 Function and Localization
- PD-L1, also known as B7-H1 or CD274, is a type I transmembrane protein belonging to the immunoglobulin superfamily.
- Functions as a ligand for the inhibitory receptor PD-1 (PDCD1), playing a critical role in maintaining immune tolerance by modulating T-cell activation thresholds and limiting effector responses (PubMed:11015443, PubMed:28813410, PubMed:28813417).
Related references:
PMID:11015443
PMID:28813410
PMID:28813417 - Through an unknown activating receptor, PD-L1 may costimulate T-cell subsets that predominantly produce IL-10 (PubMed:10581077).
Related references:
PMID:10581077 - In response to hypoxia, PD-L1 can translocate to the nucleus and act as a transcription coactivator, promoting GSDMC transcription and pyroptosis (PubMed:32929201).
Related references:
PMID:32929201 - The PD-1/PD-L1 pathway is exploited by tumors to inhibit cytotoxic T lymphocyte (CTL) function, facilitating immune evasion (PubMed:28813410, PubMed:28813417). Blockade of this pathway can reverse T-cell exhaustion, underpinning cancer immunotherapy (By similarity).
Related references:
PMID:28813410
PMID:28813417 - Subcellular localization includes the cell membrane, early and recycling endosome membranes, nucleus, and secreted forms.
- Highly expressed in heart, skeletal muscle, placenta, and lung; weakly in thymus, spleen, kidney, and liver; and on activated immune cells (T-cells, B-cells, dendritic cells, monocytes).
- Keywords: Adaptive immunity, alternative splicing, glycoprotein, immunoglobulin domain, transmembrane, and Ubl conjugation.
Experimental Guidance and Technical Tips
- The immunogen corresponds to the extracellular domain (amino acids 1-290) of human PD-L1, which is well-suited for generating antibodies that recognize the native conformation on live cells.
- This conjugate is optimized for direct flow cytometry; consider titrating the antibody to determine the optimal staining concentration for your specific cell type and experimental conditions.
- Include appropriate isotype controls and fluorescence-minus-one (FMO) controls to ensure specificity in flow cytometry assays.
- For dual-color or multicolor flow cytometry, verify fluorophore compatibility and perform compensation as needed.
- Validate reactivity in your target cell line or primary cells, as PD-L1 expression can vary with activation state and microenvironment.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio is your dedicated partner for diagnostic raw-material sourcing, connecting manufacturers and laboratories with premium monoclonal antibodies like this anti-PD-L1 reagent. Focusing on immune checkpoint research and immuno-oncology applications, we supply validated antibody pairs, optimized monoclonal/polyclonal antibodies, bulk ancillary reagents, and rare target raw materials—simplifying your supply chain from concept to clinic.
Product Datasheet
Anti-PD-L1/CD274 Monoclonal Antibody for FC - Q9NZQ7
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!